Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Capecitabine on the Pharmacokinetics of BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies

NCT00207129 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT00207129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00207129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Capecitabine on the Pharmacokinetics of BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies
Lead sponsor
R-Pharm
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2004
Completion date
December 31, 2005
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, neoplasms